Avontec
Latest round
- Series B
Last raised
- Aug 2005
Total raised
- $18M
Investors
- 4
About Avontec
Founded in 2001, Avontec GmbH is the development and commercialization of nucleic acid-based therapeutic treatments for inflammatory diseases.
Who invested in Avontec
4 investors across 1 round
See all investors in Avontec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 11, 2005
Amount
$18M
Investors
Questions about Avontec
Who invested in Avontec?
Avontec has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avontec raised?
Avontec has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Avontec last raise money?
Avontec's most recent round on record is a Series B, in Aug 2005.
What does Avontec do?
Founded in 2001, Avontec GmbH is the development and commercialization of nucleic acid-based therapeutic treatments for inflammatory diseases.
Where is Avontec headquartered?
Avontec is headquartered in Germany.
Which VCs invest in companies like Avontec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Avontec's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Avontec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.